These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16044540)

  • 1. Synthesis of linear, branched, and cyclic peptide chimera.
    Mezö G; Hudecz F
    Methods Mol Biol; 2005; 298():63-76. PubMed ID: 16044540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antibody recognition of cyclic epitope peptides, together with their dimer and conjugated derivatives based on residues 9-22 of herpes simplex virus type 1 glycoprotein D.
    Jakab A; Schlosser G; Feijlbrief M; Welling-Wester S; Manea M; Vila-Perello M; Andreu D; Hudecz F; Mezo G
    Bioconjug Chem; 2009 Apr; 20(4):683-92. PubMed ID: 19271736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and immunological studies of alpha-conotoxin chimera containing an immunodominant epitope from the 268-284 region of HSV gD protein.
    Mezo G; Drakopoulou E; Paál V; Rajnavölgyi E; Vita C; Hudecz F
    J Pept Res; 2000 Jan; 55(1):7-17. PubMed ID: 10667856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antibody recognition of mucin 1 (MUC1)-alpha-conotoxin chimera.
    Drakopoulou E; Uray K; Mezö G; Price MR; Vita C; Hudecz F
    J Pept Sci; 2000 Apr; 6(4):175-85. PubMed ID: 10809390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide based vaccine design: synthesis and immunological characterization of branched polypeptide conjugates comprising the 276-284 immunodominant epitope of HSV-1 glycoprotein D.
    Mezo G; Dalmadi B; Mucsi I; Bosze S; Rajnavölgyl E; Hudecz F
    J Pept Sci; 2002 Mar; 8(3):107-17. PubMed ID: 11931583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and comparison of antibody recognition of conjugates containing herpes simplex virus type 1 glycoprotein D epitope VII.
    Mezö G; de Oliveira E; Krikorian D; Feijlbrief M; Jakab A; Tsikaris V; Sakarellos C; Welling-Wester S; Andreu D; Hudecz F
    Bioconjug Chem; 2003; 14(6):1260-9. PubMed ID: 14624643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophobic alpha-helices 1 and 2 of herpes simplex virus gH interact with lipids, and their mimetic peptides enhance virus infection and fusion.
    Gianni T; Fato R; Bergamini C; Lenaz G; Campadelli-Fiume G
    J Virol; 2006 Aug; 80(16):8190-8. PubMed ID: 16873275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometric and chemical stability of the Asp-Pro bond in herpes simplex virus epitope peptides compared with X-Pro bonds of related sequences.
    Skribanek Z; Mezo G; Mák M; Hudecz F
    J Pept Sci; 2002 Aug; 8(8):398-406. PubMed ID: 12212803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of cyclic Herpes simplex virus peptides containing 281-284 epitope of glycoprotein D-1 in endo- or exo-position.
    Mezö G; Majer Z; Valero ML; Andreu D; Hudecz F
    J Pept Sci; 1999 Jun; 5(6):272-82. PubMed ID: 10463782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heptad repeat 2 in herpes simplex virus 1 gH interacts with heptad repeat 1 and is critical for virus entry and fusion.
    Gianni T; Piccoli A; Bertucci C; Campadelli-Fiume G
    J Virol; 2006 Mar; 80(5):2216-24. PubMed ID: 16474129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimerism: a strategy to expand the utility and applications of peptides.
    Howl J
    Methods Mol Biol; 2005; 298():25-41. PubMed ID: 16044538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of conjugation with polypeptide carrier on the enzymatic degradation of Herpes simplex virus glycoprotein D derived epitope peptide.
    Tugyi R; Mezõ G; Gitta S; Fellinger E; Andreu D; Hudecz F
    Bioconjug Chem; 2008 Aug; 19(8):1652-9. PubMed ID: 18651758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification and characterization of fusogenic domains in herpes virus glycoprotein B molecules.
    Galdiero S; Vitiello M; D'Isanto M; Falanga A; Cantisani M; Browne H; Pedone C; Galdiero M
    Chembiochem; 2008 Mar; 9(5):758-67. PubMed ID: 18311743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational study of linear and cyclic peptides corresponding to the 276-284 epitope region of HSV gD-1.
    Meźó G; Majer Z; Vass E; Jimenez MA; Andreu D; Hudecz F
    Biophys Chem; 2003 Jan; 103(1):51-65. PubMed ID: 12504254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manipulation of epitope function by modification of peptide structure: a minireview.
    Hudecz F
    Biologicals; 2001; 29(3-4):197-207. PubMed ID: 11851316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins.
    Kouvatsis V; Argnani R; Tsitoura E; Arsenakis M; Georgopoulou U; Mavromara P; Manservigi R
    Virus Res; 2007 Jan; 123(1):40-9. PubMed ID: 16989918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of sequential oligopeptide carriers on the bioactive structure of conjugated epitopes: comparative study of the conformation of a Herpes simplex virus glycoprotein gD-1 epitope in the free and conjugated form, and protein "built-in" crystal structure.
    Krikorian D; Stavrakoudis A; Biris N; Sakarellos C; Andreu D; de Oliveira E; Mezö G; Majer Z; Hudecz F; Welling-Wester S; Cung MT; Tsikaris V
    Biopolymers; 2006; 84(4):383-99. PubMed ID: 16493659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.
    Roller DG; Dollery SJ; Doyle JL; Nicola AV
    Virology; 2008 Dec; 382(2):207-16. PubMed ID: 18950828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.